Author
Listed:
- Joshua S. Siegel
(Washington University School of Medicine)
- Subha Subramanian
(Beth Israel Deaconess Medical Center)
- Demetrius Perry
(Washington University School of Medicine)
- Benjamin P. Kay
(Washington University School of Medicine)
- Evan M. Gordon
(Washington University School of Medicine)
- Timothy O. Laumann
(Washington University School of Medicine)
- T. Rick Reneau
(Washington University School of Medicine)
- Nicholas V. Metcalf
(Washington University School of Medicine)
- Ravi V. Chacko
(Advocate Christ Health Care)
- Caterina Gratton
(Florida State University)
- Christine Horan
(Miami VA Medical Center)
- Samuel R. Krimmel
(Washington University School of Medicine)
- Joshua S. Shimony
(Washington University School of Medicine)
- Julie A. Schweiger
(Washington University School of Medicine)
- Dean F. Wong
(Washington University School of Medicine)
- David A. Bender
(Washington University School of Medicine)
- Kristen M. Scheidter
(Washington University School of Medicine)
- Forrest I. Whiting
(Washington University School of Medicine)
- Jonah A. Padawer-Curry
(Washington University in St Louis)
- Russell T. Shinohara
(University of Pennsylvania
University of Pennsylvania
University of Pennsylvania)
- Yong Chen
(University of Pennsylvania)
- Julia Moser
(University of Minnesota
University of Minnesota)
- Essa Yacoub
(University of Minnesota)
- Steven M. Nelson
(University of Minnesota
University of Minnesota)
- Luca Vizioli
(University of Minnesota)
- Damien A. Fair
(University of Minnesota
University of Minnesota
University of Minnesota
University of Minnesota)
- Eric J. Lenze
(Washington University School of Medicine)
- Robin Carhart-Harris
(University of California
Imperial College London)
- Charles L. Raison
(Usona Institute
University of Wisconsin School of Medicine & Public Health)
- Marcus E. Raichle
(Washington University School of Medicine
Washington University School of Medicine
Washington University in St Louis
Washington University in St Louis)
- Abraham Z. Snyder
(Washington University School of Medicine
Washington University School of Medicine)
- Ginger E. Nicol
(Washington University School of Medicine)
- Nico U. F. Dosenbach
(Washington University School of Medicine
Washington University School of Medicine
Washington University in St Louis
Washington University in St Louis)
Abstract
A single dose of psilocybin, a psychedelic that acutely causes distortions of space–time perception and ego dissolution, produces rapid and persistent therapeutic effects in human clinical trials1–4. In animal models, psilocybin induces neuroplasticity in cortex and hippocampus5–8. It remains unclear how human brain network changes relate to subjective and lasting effects of psychedelics. Here we tracked individual-specific brain changes with longitudinal precision functional mapping (roughly 18 magnetic resonance imaging visits per participant). Healthy adults were tracked before, during and for 3 weeks after high-dose psilocybin (25 mg) and methylphenidate (40 mg), and brought back for an additional psilocybin dose 6–12 months later. Psilocybin massively disrupted functional connectivity (FC) in cortex and subcortex, acutely causing more than threefold greater change than methylphenidate. These FC changes were driven by brain desynchronization across spatial scales (areal, global), which dissolved network distinctions by reducing correlations within and anticorrelations between networks. Psilocybin-driven FC changes were strongest in the default mode network, which is connected to the anterior hippocampus and is thought to create our sense of space, time and self. Individual differences in FC changes were strongly linked to the subjective psychedelic experience. Performing a perceptual task reduced psilocybin-driven FC changes. Psilocybin caused persistent decrease in FC between the anterior hippocampus and default mode network, lasting for weeks. Persistent reduction of hippocampal-default mode network connectivity may represent a neuroanatomical and mechanistic correlate of the proplasticity and therapeutic effects of psychedelics.
Suggested Citation
Joshua S. Siegel & Subha Subramanian & Demetrius Perry & Benjamin P. Kay & Evan M. Gordon & Timothy O. Laumann & T. Rick Reneau & Nicholas V. Metcalf & Ravi V. Chacko & Caterina Gratton & Christine Ho, 2024.
"Psilocybin desynchronizes the human brain,"
Nature, Nature, vol. 632(8023), pages 131-138, August.
Handle:
RePEc:nat:nature:v:632:y:2024:i:8023:d:10.1038_s41586-024-07624-5
DOI: 10.1038/s41586-024-07624-5
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:632:y:2024:i:8023:d:10.1038_s41586-024-07624-5. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.